Stereotactic radiosurgery linear particle accelerator HyperArc
with robotized positioning tablewith multi-leaf collimator (MLC)

stereotactic radiosurgery linear particle accelerator
stereotactic radiosurgery linear particle accelerator
stereotactic radiosurgery linear particle accelerator
Add to favorites
Compare this product
 

Characteristics

Type of therapy
stereotactic radiosurgery
Components
with robotized positioning table, with multi-leaf collimator (MLC)

Description

Stereotactic radiosurgery solution Optimization Tools SRS-specific optimization tools to optimize not only dose, but also treatment delivery in Eclipse™. 2 Target Quality Metrics SRS- specific quality metrics are included within HyperArc™ to assist you in achieving the desired, optimal plan quality. 3 1-click treatment delivery HyperArc treatment delivery can even be achieved with a single click of the console (post setup), including intrafraction imaging. 4 Pre-defined Imaging WayPoints During a complex non-coplanar treatment, determining safe locations for acquiring images can be challenging. HyperArc addresses this by pre-populating a set of known safe Imaging WayPoints throughout the delivery sequence. 5 Virtual Dry Run Many clinics spend valuable resources conducting a physical dry run on the treatment delivery system to mitigate collision risk. We addressed this challenge by developing a new set of advanced visualization tools to display the treatment delivery sequence during treatment planning itself. 6 Class Solution HyperArc is provided as an end-to-end class solution for the treatment of intracranial targets. Delivery sequences are derived from a superset of trajectories. Immobilization is pre-defined, and intrafraction imaging and patient setup are prescribed.

VIDEO

Catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.